USD
GBP 
CNY 
EUR 
INR 
JPY 
MYR 
ZAR 
KRW 
THB 
Molecular POCT Unlocking Growth Potential in the Distributed Diagnostic Data Ecosystem
15-Nov-2023
North America
Market Research
K973-01-00-00-00
HC_2023_319
This study provides an overview of the global point-of-care testing (POCT) industry, which refers to any routine or specialized lab pathology
testing conducted rapidly, on-site/near the site of the patient, where care or treatment is provided. COVID-19 radicalization is changing the global diagnostics landscape. Consolidation trends, structural shifts in healthcare settings, and the extension of POCT to sexually transmitted infections (STIs), antimicrobial resistance (AMR), routine testing, oncology, and newborn screening are shaping new frontiers. In the future, therapy areas such as oncology, stroke, and dementia will represent the POCT repertoire.
In developed economies, the proliferation of syndromic testing, multiplexing making inroads in immunoassay, evolution in nucleic acid
amplification technology (from PCR to Isothermal Amplification), the use of saliva specimens, and advancements in antimicrobial resistance
testing are increasing the market viability. Furthermore, AI/ML-enabled device software functions incorporating predetermined change control
plans under the diagnostic data program initiative offer accelerated market opportunities in the United States.
In developing economies, multiparametric platforms have emerged to respond to an escalating POC demand in emergency departments and
small-medium labs. In addition, a strong pull toward preventive health is laying the foundation to advance routine testing using emerging blood testing platforms.
A robust multiplex ecosystem tied with the converging potential of diagnostic data creating new revenue streams (e.g., connectivity and digital healthcare technology services) exemplifies the pivot from COVID-19 testing, adapting to changing clinical pathways and greater harmonization
of lab-based and non-lab-based diagnostic data for similar tests to build a more sustainable point-of-care ecosystem.
Author: Amartya Bose
Why is it Increasingly Difficult to Grow?
The Strategic Imperative 8™
The Impact of the Top 3 Strategic Imperatives on the Point-of-care Testing (POCT) Industry
Growth Opportunities Fuel the Growth Pipeline Engine™
Scope of Analysis
Scope of Analysis (continued)
Segmentation—Test Type
Segmentation—Care Continuum
Key Competitors
Growth Metrics
Growth Drivers
Growth Drivers (continued)
Growth Restraints
Growth Restraints (continued)
Forecast Assumptions
Revenue Forecast
Revenue Forecast by Test Type
Revenue Forecast by Region
Revenue Forecast by Care Continuum
Forecast Analysis
Forecast Analysis (continued)
Forecast Analysis (continued)
Forecast Analysis (continued)
Forecast Analysis (continued)
Forecast Analysis (continued)
Pricing Trends and Forecast Analysis
Competitive Environment
POCT Across Different Therapy Areas
Revenue Share
Revenue Share Analysis
Revenue Share Analysis (continued)
Revenue Share Analysis (continued)
Revenue Share Analysis (continued)
Competitor Matrix—Therapy Areas
Competitor Matrix—Technology Mapping
Growth Metrics
Revenue Forecast
Revenue Forecast by Region
Revenue Forecast by Immunochemistry POCT
Forecast Analysis
Forecast Analysis (continued)
Forecast Analysis (continued)
Forecast Analysis (continued)
Growth Metrics
Revenue Forecast
Revenue Forecast by Region
Revenue Forecast by Molecular POCT Therapy Areas
Forecast Analysis
Forecast Analysis (continued)
Forecast Analysis (continued)
Forecast Analysis (continued)
Growth Opportunity 1: Molecular POCT
Growth Opportunity 1: Molecular POCT (continued)
Growth Opportunity 2: Multiplexing
Growth Opportunity 2: Multiplexing (continued)
Growth Opportunity 3: STI POCT
Growth Opportunity 3: STI POCT (continued)
Growth Opportunity 4: AMR POCT
Growth Opportunity 4: AMR POCT (continued)
Growth Opportunity 5: Routine POCT
Growth Opportunity 5: Routine POCT (continued)
Growth Opportunity 6: Smartphone POCT
Growth Opportunity 6: Smartphone POCT (continued)
Future of POCT in Care Continuum
Your Next Steps
Why Frost, Why Now?
List of Exhibits
Legal Disclaimer
List of Figures
- POCT Industry: Growth Metrics, Global, 2023
- POCT Industry: Growth Drivers, Global, 2024–2028
- POCT Industry: Growth Restraints, Global, 2024–2028
- POCT Industry: Revenue Forecast, Global, 2023–2028
- POCT Industry: Revenue Forecast by Test Type, Global, 2023–2028
- POCT Industry: Revenue Forecast by Region, 2023–2028
- POCT Industry: Revenue Forecast by Care Continuum, Global, 2023–2028
- POCT Industry: Revenue Share of Top Participants, Global, 2023
- POCT Industry: Competitor Matrix for Therapy Area Portfolio Assessment, Global, 2023
- Immunochemistry POCT: Growth Metrics, Global, 2023
- Immunochemistry POCT: Revenue Forecast, Global, 2023–2028
- Immunochemistry POCT: Revenue Forecast by Region, 2023–2028
- Immunochemistry POCT Industry: Revenue Forecast by Therapy Areas, 2023–2028
- Molecular POCT: Growth Metrics, Global, 2023
- Molecular POCT: Revenue Forecast, Global, 2023–2028
- Molecular POCT: Revenue Forecast by Region, 2023–2028
- Molecular POCT Industry: Revenue Forecast by Therapy Areas, Global, 2023–2028
Speak directly with our analytics experts for tailored recommendations.
Recent related Healthcare research
15 Sep 2026 | Global | Market Research
Vendor Profiles: Advanced Wound Care Management Market, Global, 2025
The wound care market is being transformed by advanced technologies and evolving care models that focus on improving patient outcomes and reducing healthcare costs. Innovations such as smart sensor-embedded dressings, artificial intelligence (AI)-based wound imaging systems, enhanced negative pressu...
11 Sep 2026 | Global | Frost Radar
Frost Radar™: Pharmaceutical Commercialization Solutions and Services, 2026
Pharmaceutical commercialization is a multidimensional concept in the successful launch and distribution of a drug. The process includes the development of a pricing strategy that reflects the drug’s value, negotiation with payers to ensure drug cost coverage, regulatory compliance, and the generati...
07 Sep 2026 | Global | Technology Research
Synthetic Antibodies and AI-Optimized Immunotherapies
Artificial intelligence is becoming increasingly relevant to antibody discovery and immunotherapy development, supporting target identification, de novo antibody design, antibody engineering, clinical intelligence, and bioprocessing. Advances in generative AI, protein language models, diffusion mode...
28 Aug 2026 | Global | Technology Research
Innovations and Growth Opportunities in Advanced Medical Devices, Artificial Intelligence Solutions, Digital Solutions, and Medical Imaging Solutions
The latest issue of Advanced MedTech Technology Opportunity Engine (TOE) spotlights a diverse slate of innovations across advanced medical devices, artificial intelligence solutions, digital solutions, and medical imaging solutions.The issue features advanced medical devices such as active bioelectr...
27 Aug 2026 | Global | Frost Radar
Frost Radar: AI-Powered Molecular Diagnostics, 2026
AI-powered molecular diagnostics is an emerging and moderately fragmented industry that includes molecular diagnostics companies, precision medicine platforms, sequencing specialists, AI-driven analytics providers, and disease-focused biotechnology companies. No single company has dominated, present...
Purchase includes:
- Report download
- Growth Dialog™ with our experts
Growth Dialog™
A tailored session with you where we identify the:- Strategic Imperatives
- Growth Opportunities
- Best Practices
- Companies to Action
Impacting your company's future growth potential.
| Deliverable Type | Market Research |
|---|---|
| Author | Amartya Bose |
| Industries | Healthcare |
| No Index | No |
| Is Prebook | No |
| Keyword 1 | Point Of Care Molecular Diagnostics |
| Keyword 2 | Poc Testing Trends |
| Keyword 3 | Point-Of-Care Testing Insights |
| List of Charts and Figures | POCT Industry: Growth Metrics, Global, 2023~ POCT Industry: Growth Drivers, Global, 2024–2028~ POCT Industry: Growth Restraints, Global, 2024–2028~ POCT Industry: Revenue Forecast, Global, 2023–2028~ POCT Industry: Revenue Forecast by Test Type, Global, 2023–2028~ POCT Industry: Revenue Forecast by Region, 2023–2028~ POCT Industry: Revenue Forecast by Care Continuum, Global, 2023–2028~ POCT Industry: Revenue Share of Top Participants, Global, 2023~ POCT Industry: Competitor Matrix for Therapy Area Portfolio Assessment, Global, 2023~ Immunochemistry POCT: Growth Metrics, Global, 2023~ Immunochemistry POCT: Revenue Forecast, Global, 2023–2028~ Immunochemistry POCT: Revenue Forecast by Region, 2023–2028~ Immunochemistry POCT Industry: Revenue Forecast by Therapy Areas, 2023–2028~ Molecular POCT: Growth Metrics, Global, 2023~ Molecular POCT: Revenue Forecast, Global, 2023–2028~ Molecular POCT: Revenue Forecast by Region, 2023–2028~ Molecular POCT Industry: Revenue Forecast by Therapy Areas, Global, 2023–2028~ |
| Podcast | No |
| WIP Number | K973-01-00-00-00 |